SCHEMBL19645306

SCHEMBL19645306

CC(C)(C)OC(=O)n1ccc2c(Cl)c(O[Si](C)(C)C(C)(C)C)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.41
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
HTR6 P50406 1/20 0.35
BUB1 O43683 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AKT1 P31749 1/20 0.34
BRD4 O60885 2/20 0.34
PIK3CA P42336 3/20 0.33
PIK3CD O00329 2/20 0.33
ABL1 P00519 2/20 0.33
EGFR P00533 2/20 0.33
HCK P08631 2/20 0.33
SRC P12931 2/20 0.33
KDR P35968 2/20 0.33
PIK3CB P42338 2/20 0.33
MTOR P42345 2/20 0.33
PIK3CG P48736 2/20 0.33
EPHB4 P54760 2/20 0.33
PRKDC P78527 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3044688 0.84 AKT1 (0.40) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL29992652 0.84 AKT1 (0.40) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL12422261 0.79 NOTUM (0.47) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL19645303 0.79 NOTUM (0.47) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL14722904 0.78 NOTUM (0.43) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL29631795 0.76 L3MBTL1 (0.44) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL18989920 0.76 NOTUM (0.43) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL18990682 0.76 L3MBTL1 (0.44) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL29631950 0.76 NOTUM (0.43) NOTUMHSP90AA1HSP90AB1HTR6BUB1
SCHEMBL1550722 0.76 GABRG2 (0.37) GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3009436-B1 KINASE INHIBITORS AND METHODS OF USE INTELLIKINE LLC (US) 2019-06-05 EP disclosed
US-9828378-B2 Kinase inhibitors and methods of use INTELLIKINE LLC (US) 2017-11-28 US disclosed